Loading...
Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trial.
Nutting, C Morden, J Harrington, K Urbano, Teresa G Bhide, S A Clark, C Miles, E A Miah, A B Newbold, K Tanay, M A
Nutting, C
Morden, J
Harrington, K
Urbano, Teresa G
Bhide, S A
Clark, C
Miles, E A
Miah, A B
Newbold, K
Tanay, M A
Citations
Altmetric:
Abstract
Xerostomia is the most common late side-effect of radiotherapy to the head and neck. Compared with conventional radiotherapy, intensity-modulated radiotherapy (IMRT) can reduce irradiation of the parotid glands. We assessed the hypothesis that parotid-sparing IMRT reduces the incidence of severe xerostomia.
Description
Date
2011-02
Publisher
Collections
Keywords
Type
Article
Citation
Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trial. 2011, 12 (2):127-36 Lancet Oncol.